Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study | 111 |
| Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study | 63 |
Total Visits per Month
| December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | |
|---|---|---|---|---|---|---|---|
| Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study | 0 | 0 | 0 | 4 | 3 | 3 | 0 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| Australia | 77 |
| United States | 43 |
| China | 18 |
| Netherlands | 8 |
| Vietnam | 6 |
| Sweden | 3 |
| Singapore | 3 |
| Germany | 2 |
| Hong Kong SAR China | 2 |
| France | 1 |
Top City Views
| Views | |
|---|---|
| Kaleen | 31 |
| Ashburn | 30 |
| Beijing | 8 |
| Rotterdam | 8 |
| Hanoi | 5 |
| Zhengzhou | 5 |
| Cambridge | 3 |
| Central | 2 |
| Changchun | 2 |
| Fairfield | 2 |